- Home
- WIA vs SOPH Comparison
WIA vs SOPH Comparison
Compare WIA & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIA
- SOPH
- Stock Information
- Founded
- WIA 2003
- SOPH 2011
- Country
- WIA United States
- SOPH Switzerland
- Employees
- WIA N/A
- SOPH N/A
- Industry
- WIA Trusts Except Educational Religious and Charitable
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WIA Finance
- SOPH Health Care
- Exchange
- WIA Nasdaq
- SOPH Nasdaq
- Market Cap
- WIA 186.8M
- SOPH 207.3M
- IPO Year
- WIA N/A
- SOPH 2021
- Fundamental
- Price
- WIA $8.09
- SOPH $3.25
- Analyst Decision
- WIA
- SOPH Strong Buy
- Analyst Count
- WIA 0
- SOPH 3
- Target Price
- WIA N/A
- SOPH $7.00
- AVG Volume (30 Days)
- WIA 39.2K
- SOPH 39.5K
- Earning Date
- WIA 01-01-0001
- SOPH 03-04-2025
- Dividend Yield
- WIA 12.29%
- SOPH N/A
- EPS Growth
- WIA N/A
- SOPH N/A
- EPS
- WIA N/A
- SOPH N/A
- Revenue
- WIA N/A
- SOPH $64,488,000.00
- Revenue This Year
- WIA N/A
- SOPH $6.55
- Revenue Next Year
- WIA N/A
- SOPH $14.37
- P/E Ratio
- WIA N/A
- SOPH N/A
- Revenue Growth
- WIA N/A
- SOPH 9.85
- 52 Week Low
- WIA $7.56
- SOPH $2.70
- 52 Week High
- WIA $8.91
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- WIA 51.52
- SOPH 51.14
- Support Level
- WIA $7.94
- SOPH $2.93
- Resistance Level
- WIA $8.18
- SOPH $3.60
- Average True Range (ATR)
- WIA 0.08
- SOPH 0.24
- MACD
- WIA 0.02
- SOPH 0.01
- Stochastic Oscillator
- WIA 65.20
- SOPH 50.49
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.